Her primary interest is in optimizing the delivery of health services for infectious diseases, specifically HIV and hepatitis C virus (HCV) infection. Her work has focused on preexposure prophylaxis for HIV prevention, as well as the long-term outcomes of chronic HIV infection. She also received a career development award (K01) from the National Institute of Allergy and Infectious Diseases to study the dissemination of highly effective hepatitis C treatment, with a focus on HIV/HCV-coinfected patients.